In Washington, DC and state capitals around the country, Lupus Foundation of America advocates tell their stories and urge ...

Supporting lupus patients and advocates in Arizona.

A lupus diagnosis can profoundly affect many aspects of a man’s life, from sense of identity and mental health to the way one ...

The Michael Jon Barlin Pediatric Lupus Research program provides funding for research projects that have the potential to ...

The U.S. Food & Drug Administration (FDA) has granted approval for a new subcutaneous autoinjector formulation of belimumab ...

Stay up to date on the latest lupus information, research, clinical guidelines and resources for you and your patients.

Researchers from EMD Serono and global collaborators shared promising results from Cohort B of the phase II trial of the WILLOW study.

The Lupus & You: Empowerment conference is an experience that celebrates, inspires, supports, and uplifts lupus warriors, care partners, family, and friends. During this empowering day, attendees will ...

Cullinan Therapeutics has announced a licensing agreement with Genrix Bio for global rights to velinotamig, a clinical -stage BCMAxCD3 bispecific T cell engager. The agreement allows Cullinan to ...

Lupus Foundation of America, Texas Gulf Coast Chapter 440 Louisiana St Ste 900C Houston, Texas 77002 713-529-0126 Fax: 713-529-0780 [email protected] ...

In this episode of the Lupus Foundation of America's The Expert Series podcast, we explore the intersection of menopause and lupus, highlighting the unique challenges faced by women with lupus during ...

The Lupus Foundation of America is profoundly concerned by the reorganization and significant staff reductions taking place at the U.S. Department of Health and Human Services (HHS) in addition to ...